Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 21 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 12, 2018 Filed Jan 26, 2018 16:23 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 2,150 | $0.00 Strike: $52.29 | $0.00 |
DisclosureSEC source: 0001209191-18-005587 · doc4.xml · derivative · entry 3 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,850 Underlying: Common stock · 2,150 shares Expires 2026-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: This option was granted on November 7, 2016. The shares underlying this option vest as to 25% of the underlying shares on November 7, 2017, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| January 12, 2018 Filed Jan 26, 2018 16:23 UTC |
Alenson CarmanPrincipal Accounting Officer
|
SaleCommon stock | 2,150 | $75.00 | $161,250.00 |
DisclosureSEC source: 0001209191-18-005587 · doc4.xml · nonDerivative · entry 2 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 12, 2018 Filed Jan 26, 2018 16:23 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Exercise / conversionCommon stock | 2,150 | $52.29 | $112,423.50 |
DisclosureSEC source: 0001209191-18-005587 · doc4.xml · nonDerivative · entry 1 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 10, 2018 Filed Jan 12, 2018 21:34 UTC |
Biller ScottChief Scientific Officer
|
Exercise / conversionStock options (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001209191-18-003434 · doc4.xml · derivative · entry 3 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,867 Underlying: Common stock · 3,000 shares Expires 2020-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: This option was granted on December 7, 2010. The shares underlying this option vested as to 25% of the shares upon the achievement of a performance milestone, and as to the remaining 75% in 36 equal monthly installments thereafter. The performance criteria was met on June 23, 2015. Read SEC document |
| January 10, 2018 Filed Jan 12, 2018 21:34 UTC |
Biller ScottChief Scientific Officer
|
SaleCommon stock | 3,000 | $65.00 | $195,000.00 |
DisclosureSEC source: 0001209191-18-003434 · doc4.xml · nonDerivative · entry 2 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,059 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 10, 2018 Filed Jan 12, 2018 21:34 UTC |
Biller ScottChief Scientific Officer
|
Exercise / conversionCommon stock | 3,000 | $0.47 | $1,402.50 |
DisclosureSEC source: 0001209191-18-003434 · doc4.xml · nonDerivative · entry 1 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:23 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 631 | $60.45 | $38,143.95 |
DisclosureSEC source: 0001209191-17-064704 · doc4.xml · nonDerivative · entry 10 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 79,515 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.00 to $60.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:23 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 631 | $60.45 | $38,143.95 |
DisclosureSEC source: 0001209191-17-064704 · doc4.xml · nonDerivative · entry 9 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,475 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.00 to $60.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:23 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 288 | $59.68 | $17,187.84 |
DisclosureSEC source: 0001209191-17-064704 · doc4.xml · nonDerivative · entry 8 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 80,146 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.99 to $59.95. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:23 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 288 | $59.68 | $17,187.84 |
DisclosureSEC source: 0001209191-17-064704 · doc4.xml · nonDerivative · entry 7 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,106 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.99 to $59.95. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 21:23 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 204 | $60.01 | $12,242.04 |
DisclosureSEC source: 0001209191-17-064704 · doc4.xml · nonDerivative · entry 6 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 80,434 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.62 to $60.55. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 21:23 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 204 | $60.01 | $12,242.04 |
DisclosureSEC source: 0001209191-17-064704 · doc4.xml · nonDerivative · entry 5 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,394 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.62 to $60.55. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 21:23 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 254 | $58.95 | $14,973.30 |
DisclosureSEC source: 0001209191-17-064704 · doc4.xml · nonDerivative · entry 4 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 80,638 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.58 to $59.21. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 21:23 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 253 | $58.95 | $14,914.35 |
DisclosureSEC source: 0001209191-17-064704 · doc4.xml · nonDerivative · entry 3 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,598 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.58 to $59.21. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 21:23 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 542 | $57.90 | $31,381.80 |
DisclosureSEC source: 0001209191-17-064704 · doc4.xml · nonDerivative · entry 2 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 80,892 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $57.48 to $58.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 21:23 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 543 | $57.90 | $31,439.70 |
DisclosureSEC source: 0001209191-17-064704 · doc4.xml · nonDerivative · entry 1 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,851 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $57.48 to $58.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 21:22 UTC |
Biller ScottChief Scientific Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 31,818 | $0.00 Strike: $2.34 | $0.00 |
DisclosureSEC source: 0001209191-17-064701 · doc4.xml · derivative · entry 6 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,818 Underlying: Common stock · 31,818 shares Expires 2022-04-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted on April 6, 2012 for the purchase of 63,636 shares of common stock. The option vests as to 25% of the shares upon the achievement of a performance milestone, as to an additional 50% upon the achievement of a second performance milestone, and as to the remaining 25% on the first anniversary of the first date that both performance milestones were achieved. The performance criteria for the first performance milestone were met on March 18, 2013. The performance criteria for the second performance milestone were met on April 4, 2014, resulting in the vesting of the option as to 31,818 shares, and the remaining 15,909 shares vested on April 4, 2015. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 21:22 UTC |
Biller ScottChief Scientific Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 102 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001209191-17-064701 · doc4.xml · derivative · entry 5 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,867 Underlying: Common stock · 102 shares Expires 2020-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on December 7, 2010. The shares underlying this option vested as to 25% of the shares upon the achievement of a performance milestone, and as to the remaining 75% in 36 equal monthly installments thereafter. The performance criteria was met on June 23, 2015. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 21:22 UTC |
Biller ScottChief Scientific Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 14,875 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001209191-17-064701 · doc4.xml · derivative · entry 4 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 14,875 shares Expires 2020-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was granted on December 7, 2010. The shares underlying this option vest as to 25% of the shares on September 20, 2011, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 21:22 UTC |
Biller ScottChief Scientific Officer
|
Exercise / conversionCommon stock | 31,818 | $2.34 | $74,374.58 |
DisclosureSEC source: 0001209191-17-064701 · doc4.xml · nonDerivative · entry 3 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 21:22 UTC |
Biller ScottChief Scientific Officer
|
Exercise / conversionCommon stock | 102 | $0.47 | $47.69 |
DisclosureSEC source: 0001209191-17-064701 · doc4.xml · nonDerivative · entry 2 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 21:22 UTC |
Biller ScottChief Scientific Officer
|
Exercise / conversionCommon stock | 14,875 | $0.47 | $6,954.06 |
DisclosureSEC source: 0001209191-17-064701 · doc4.xml · nonDerivative · entry 1 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2017 Filed Dec 5, 2017 21:15 UTC |
FOUSE JACQUALYN ADirector
|
GrantStock option (right to buy) · Derivative | 16,000 | $0.00 Strike: $61.17 | $0.00 |
DisclosureSEC source: 0001209191-17-063895 · doc4.xml · derivative · entry 1 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common stock · 16,000 shares Expires 2027-12-02 F1 · derivative.exercise_date: This option was granted on December 3, 2017. The shares underlying this option vest as to 25% of the underlying shares on December 2, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 21:28 UTC |
Schenkein David PDirector · Chief Executive Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 6,000 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001209191-17-063927 · doc4.xml · derivative · entry 6 Schenkein David P · CIK 0001578200 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,656 Underlying: Common stock · 6,000 shares Expires 2019-08-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: This option was granted on August 13, 2009. The shares underlying this option vest as to 25% of the shares on August 1, 2010, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 21:28 UTC |
Schenkein David PDirector · Chief Executive Officer
|
SaleCommon stock | 400 | $62.08 | $24,832.00 |
DisclosureSEC source: 0001209191-17-063927 · doc4.xml · nonDerivative · entry 3 Schenkein David P · CIK 0001578200 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $62.04 to $62.10. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 21:28 UTC |
Schenkein David PDirector · Chief Executive Officer
|
SaleCommon stock | 5,600 | $61.51 | $344,456.00 |
DisclosureSEC source: 0001209191-17-063927 · doc4.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $61.03 to $61.91. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 21:28 UTC |
Schenkein David PDirector · Chief Executive Officer
|
Exercise / conversionCommon stock | 6,000 | $0.30 | $1,815.00 |
DisclosureSEC source: 0001209191-17-063927 · doc4.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 21:09 UTC |
Biller ScottChief Scientific Officer
|
Exercise / conversionStock options (right to buy) · Derivative | 2,146 | $0.00 Strike: $31.64 | $0.00 |
DisclosureSEC source: 0001209191-17-063884 · doc4.xml · derivative · entry 5 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,039 Underlying: Common stock · 2,146 shares Expires 2024-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: This option was granted on March 5, 2014. The shares underlying this option vest as to 25% of the shares on March 5, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 21:09 UTC |
Biller ScottChief Scientific Officer
|
SaleCommon stock | 700 | $61.76 | $43,232.00 |
DisclosureSEC source: 0001209191-17-063884 · doc4.xml · nonDerivative · entry 4 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,264 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $61.45 to $62.24. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 21:09 UTC |
Biller ScottChief Scientific Officer
|
SaleCommon stock | 846 | $60.63 | $51,292.98 |
DisclosureSEC source: 0001209191-17-063884 · doc4.xml · nonDerivative · entry 3 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,964 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.35 to $61.06. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 21:09 UTC |
Biller ScottChief Scientific Officer
|
SaleCommon stock | 600 | $59.89 | $35,934.00 |
DisclosureSEC source: 0001209191-17-063884 · doc4.xml · nonDerivative · entry 2 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,810 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.29 to $60.26. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 21:09 UTC |
Biller ScottChief Scientific Officer
|
Exercise / conversionCommon stock | 2,146 | $31.64 | $67,899.44 |
DisclosureSEC source: 0001209191-17-063884 · doc4.xml · nonDerivative · entry 1 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 01, 2017 Filed Jan 25, 2018 21:02 UTC Amendment |
Schenkein David PDirector · Chief Executive Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 6,000 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001209191-18-005355 · doc4a.xml · derivative · entry 1 Schenkein David P · CIK 0001578200 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,837 Underlying: Common stock · 6,000 shares Expires 2019-08-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: This option was granted on August 13, 2009. The shares underlying this option vest as to 25% of the shares on August 1, 2010, with the remaining 75% vesting in 36 equal monthly installments thereafter. F3 · balance_after: The original Form 4, filed on December 5, 2017, is being amended by this Form 4 amendment solely to correct the number of derivative securities beneficially owned following reported transaction. Read SEC document |
| November 14, 2017 Filed Nov 15, 2017 22:43 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 309 | $60.46 | $18,682.14 |
DisclosureSEC source: 0001209191-17-060967 · doc4.xml · nonDerivative · entry 6 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 81,434 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.19 to $60.78. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| November 14, 2017 Filed Nov 15, 2017 22:43 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 309 | $60.46 | $18,682.14 |
DisclosureSEC source: 0001209191-17-060967 · doc4.xml · nonDerivative · entry 5 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,394 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.19 to $60.78. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 14, 2017 Filed Nov 15, 2017 22:43 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 691 | $59.36 | $41,017.76 |
DisclosureSEC source: 0001209191-17-060967 · doc4.xml · nonDerivative · entry 4 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 81,743 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.05 to $59.71. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| November 14, 2017 Filed Nov 15, 2017 22:43 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 691 | $59.36 | $41,017.76 |
DisclosureSEC source: 0001209191-17-060967 · doc4.xml · nonDerivative · entry 3 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,703 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.05 to $59.71. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 22:43 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 1,000 | $62.07 | $62,070.00 |
DisclosureSEC source: 0001209191-17-060967 · doc4.xml · nonDerivative · entry 2 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 82,434 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $61.87 to $62.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 22:43 UTC |
Cantley Lewis Clayton Jr.Director
|
SaleCommon stock | 1,000 | $62.07 | $62,070.00 |
DisclosureSEC source: 0001209191-17-060967 · doc4.xml · nonDerivative · entry 1 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,394 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $61.87 to $62.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:00 UTC |
Schenkein David PDirector · Chief Executive Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 6,000 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001209191-17-059135 · doc4.xml · derivative · entry 8 Schenkein David P · CIK 0001578200 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,656 Underlying: Common stock · 6,000 shares Expires 2019-08-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F8 · derivative.exercise_date: This option was granted on August 13, 2009. The shares underlying this option vest as to 25% of the shares on August 1, 2010, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:00 UTC |
Schenkein David PDirector · Chief Executive Officer
|
SaleCommon stock | 4,260 | $63.32 | $269,743.20 |
DisclosureSEC source: 0001209191-17-059135 · doc4.xml · nonDerivative · entry 5 Schenkein David P · CIK 0001578200 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $63.13 to $64.00. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:00 UTC |
Schenkein David PDirector · Chief Executive Officer
|
SaleCommon stock | 942 | $64.64 | $60,890.88 |
DisclosureSEC source: 0001209191-17-059135 · doc4.xml · nonDerivative · entry 4 Schenkein David P · CIK 0001578200 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,260 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $64.27 to $65.23. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:00 UTC |
Schenkein David PDirector · Chief Executive Officer
|
SaleCommon stock | 598 | $65.42 | $39,121.16 |
DisclosureSEC source: 0001209191-17-059135 · doc4.xml · nonDerivative · entry 3 Schenkein David P · CIK 0001578200 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,202 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $65.32 to $65.76. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:00 UTC |
Schenkein David PDirector · Chief Executive Officer
|
SaleCommon stock | 200 | $66.75 | $13,350.00 |
DisclosureSEC source: 0001209191-17-059135 · doc4.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,800 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:00 UTC |
Schenkein David PDirector · Chief Executive Officer
|
Exercise / conversionCommon stock | 6,000 | $0.30 | $1,815.00 |
DisclosureSEC source: 0001209191-17-059135 · doc4.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:01 UTC |
Biller ScottChief Scientific Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 2,146 | $0.00 Strike: $31.64 | $0.00 |
DisclosureSEC source: 0001209191-17-059138 · doc4.xml · derivative · entry 6 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,185 Underlying: Common stock · 2,146 shares Expires 2024-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: This option was granted on March 5, 2014. The shares underlying this option vest as to 25% of the shares on March 5, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:01 UTC |
Biller ScottChief Scientific Officer
|
SaleCommon stock | 946 | $61.81 | $58,472.26 |
DisclosureSEC source: 0001209191-17-059138 · doc4.xml · nonDerivative · entry 5 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,264 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $61.36 to $62.34. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:01 UTC |
Biller ScottChief Scientific Officer
|
SaleCommon stock | 900 | $63.09 | $56,781.00 |
DisclosureSEC source: 0001209191-17-059138 · doc4.xml · nonDerivative · entry 4 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,210 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $62.57 to $63.49. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:01 UTC |
Biller ScottChief Scientific Officer
|
SaleCommon stock | 200 | $63.62 | $12,724.00 |
DisclosureSEC source: 0001209191-17-059138 · doc4.xml · nonDerivative · entry 3 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,110 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $63.60 to $63.63. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:01 UTC |
Biller ScottChief Scientific Officer
|
SaleCommon stock | 100 | $65.45 | $6,545.00 |
DisclosureSEC source: 0001209191-17-059138 · doc4.xml · nonDerivative · entry 2 Biller Scott · CIK 0001581956 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,310 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.